Capsaicin Fatty Acid Formulation for TRPV1 Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective treatments for capsaicin-responsive diseases and disorders such as cancer, obesity, diabetes, bacterial infections, cardiovascular diseases, neurodegenerative diseases, inflammatory diseases, autoimmune diseases, hypercholesterolemia, and mood disorders, which current therapies have not adequately addressed.
Innovation Solution
A composition comprising a compound of structural Formula (I) or its isotopic variant, metabolite, pharmaceutically acceptable salt, solvate, or hydrate, in combination with a fatty acid, specifically designed for oral administration, where the ratio of the compound to the fatty acid ranges from 1:5 to 1:1000, and can include capsaicin or dihydrocapsaicin, along with a TrpV1 modulator or FAAH receptor inhibitor, to treat capsaicin-responsive diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If capsaicin or its analogs are used to treat capsaicin-responsive diseases, then therapeutic benefits are achieved, but patient compliance is reduced due to unpleasant taste and pungency
Solution Approach 1:
The patent uses fatty acids as intermediary substances to mask the unpleasant taste and pungency of capsaicin. The fatty acid encapsulation acts as a mediator between the active ingredient and the patient, delivering the therapeutic agent while reducing sensory irritation and improving palatability, thereby enhancing patient compliance without compromising therapeutic efficacy
Solution Approach 2:
The patent modifies the physical and chemical parameters of capsaicin delivery by formulating it with fatty acids in specific ratios (1:5 to 1:1000). This parameter change transforms the delivery system from a direct administration of pure capsaicin to a controlled release formulation, reducing the immediate sensory impact while maintaining therapeutic effectiveness over time
2Reliability
If high concentrations of capsaicin are used to ensure therapeutic effectiveness, then treatment efficacy improves, but adverse effects and patient discomfort increase
Solution Approach 1:
The patent employs parameter changes by optimizing the concentration ratio of capsaicin to fatty acid (1:5 to 1:1000) and controlling the amount of capsaicinoid present (0.1-50% w/v). This controlled parameter adjustment allows delivery of effective therapeutic doses while the fatty acid matrix modulates the release profile, reducing peak concentrations that cause adverse effects
Solution Approach 2:
The fatty acid serves as a protective intermediary that reduces the direct contact and harmful effects of high concentrations of capsaicin on tissues. This mediator allows higher effective doses to be delivered while the fatty acid buffer minimizes local irritation and adverse reactions
3Adaptability or versatility
If capsaicin is administered to treat multiple capsaicin-responsive diseases, then broad therapeutic coverage is achieved, but the complexity of dosage formulation increases
Solution Approach 1:
The patent creates a universal fatty acid-capsaicin formulation system that can treat multiple capsaicin-responsive diseases (obesity, diabetes, inflammatory diseases, cancer, etc.) through a single platform. The standardized formulation approach with fatty acids in 1:5 to 1:1000 ratios provides a multi-functional solution that simplifies dosage formulation across different therapeutic indications
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively treats and prevents capsaicin-responsive diseases by modulating TrpV1 channels and FAAH receptors, providing therapeutic benefits for various conditions including obesity, diabetes, and inflammatory diseases, with capsaicin or dihydrocapsaicin present in amounts ranging from 0.1% to 50% (w/v).
Implementation Method 1
The composition effectively treats and prevents capsaicin-responsive diseases by modulating TrpV1 channels and FAAH receptors
Implementation Method 2
The composition effectively treats and prevents capsaicin-responsive diseases by modulating TrpV1 channels and FAAH receptors
Data Source
AI summary
Provided herein are combinations of capsaicin and TrpV1 modulators that are useful for treating capsaicin-responsive diseases or disorders.